Use and treatment of di-amino acid repeat-containing proteins associated with ALS
US12360124B2 · kind B2 · utility
0Cited by
13References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 20, 2024 |
| Grant date | Jul 15, 2025 |
| Priority date | — |
| Expiry date | May 20, 2044 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/285
- WIPO fieldChemical engineering
- WIPO sectorChemistry
Abstract
Disclosed herein are methods and compositions for identifying and/or treating subjects having or likely to have amyotrophic lateral sclerosis (ALS) or frontotemporal dementia (FTD). Antibodies specific for one or more di-amino acid repeat-containing proteins are also provided herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.